Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Markers of microbial translocation and risk of AIDS-related lymphoma.

Marks MA, Rabkin CS, Engels EA, Busch E, Kopp W, Rager H, Goedert JJ, Chaturvedi AK.

AIDS. 2013 Jan 28;27(3):469-74. doi: 10.1097/QAD.0b013e32835c1333.

PMID:
23169327
2.

B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS.

Grulich AE, Wan X, Law MG, Milliken ST, Lewis CR, Garsia RJ, Gold J, Finlayson RJ, Cooper DA, Kaldor JM.

AIDS. 2000 Jan 28;14(2):133-40.

PMID:
10708283
3.

B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma.

Breen EC, Hussain SK, Magpantay L, Jacobson LP, Detels R, Rabkin CS, Kaslow RA, Variakojis D, Bream JH, Rinaldo CR, Ambinder RF, Martinez-Maza O.

Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1303-14. doi: 10.1158/1055-9965.EPI-11-0037. Epub 2011 Apr 28.

4.

Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.

Sparano JA, Hu X, Wiernik PH, Sarta C, Reddy DM, Hanau L, Henry DH.

J Natl Cancer Inst. 1997 Feb 19;89(4):301-7.

PMID:
9048834
5.

HIV-associated immune dysfunction and viral infection: role in the pathogenesis of AIDS-related lymphoma.

Epeldegui M, Vendrame E, Martínez-Maza O.

Immunol Res. 2010 Dec;48(1-3):72-83. doi: 10.1007/s12026-010-8168-8. Review.

6.

AIDS-related cancer and severity of immunosuppression in persons with AIDS.

Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA; HIV/AIDS Cancer Match Study.

J Natl Cancer Inst. 2007 Jun 20;99(12):962-72. Epub 2007 Jun 12.

PMID:
17565153
7.

Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France.

Bonnet F, Balestre E, Thiébaut R, Morlat P, Pellegrin JL, Neau D, Dabis F; Groupe d'Epidemiologie Clinique du SIDA en Aquitaine.

Clin Infect Dis. 2006 Feb 1;42(3):411-7. Epub 2005 Dec 27.

PMID:
16392091
8.

Microbial translocation and AIDS-associated lymphomas: crux of the problem.

Allam O, Samarani S, Ahmad A.

AIDS. 2013 Jan 28;27(3):477-8. doi: 10.1097/QAD.0b013e32835cba91. No abstract available.

PMID:
23291542
9.

Serum biomarkers of immune activation and subsequent risk of non-hodgkin B-cell lymphoma among HIV-infected women.

Hussain SK, Hessol NA, Levine AM, Breen EC, Anastos K, Cohen M, D'Souza G, Gustafson DR, Silver S, Martínez-Maza O.

Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):2084-93. doi: 10.1158/1055-9965.EPI-13-0614. Epub 2013 Sep 17.

10.

TLR2-activated B cells are phenotypically similar to the abnormal circulating B cells seen preceding the diagnosis of AIDS-related NHL diagnosis.

Guo Y, Siewe B, Epeldegui M, Detels R, Landay AL, Martínez-Maza O.

J Acquir Immune Defic Syndr. 2013 Oct 1;64(2):204-10. doi: 10.1097/QAI.0b013e31829d4d50.

11.

Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals.

Abad-Fernández M, Vallejo A, Hernández-Novoa B, Díaz L, Gutiérrez C, Madrid N, Muñoz MA, Moreno S.

J Acquir Immune Defic Syndr. 2013 Oct 1;64(2):149-53. doi: 10.1097/QAI.0b013e31829a2f12.

PMID:
24047967
12.

Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults.

Jaffe HW, De Stavola BL, Carpenter LM, Porter K, Cox DR; CASCADE Collaboration.

AIDS. 2011 Jul 17;25(11):1395-403. doi: 10.1097/QAD.0b013e3283489c8b.

PMID:
21572307
13.

HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons.

Chao C, Xu L, Abrams DI, Towner WJ, Horberg MA, Leyden WA, Silverberg MJ.

AIDS. 2011 Sep 10;25(14):1771-7. doi: 10.1097/QAD.0b013e328349c67a.

14.

Hodgkin lymphoma is as common as non-Hodgkin lymphoma in HIV-positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort study.

Hoffmann C, Hentrich M, Gillor D, Behrens G, Jensen B, Stoehr A, Esser S, van Lunzen J, Krznaric I, Müller M, Oette M, Hensel M, Thoden J, Fätkenheuer G, Wyen C.

HIV Med. 2015 Apr;16(4):261-4. doi: 10.1111/hiv.12200. Epub 2014 Sep 23.

15.

Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma.

Piriou E, van Dort K, Nanlohy NM, van Oers MH, Miedema F, van Baarle D.

Blood. 2005 Nov 1;106(9):3166-74. Epub 2005 Jul 12.

16.

Immunologic and virologic predictors of AIDS-related non-hodgkin lymphoma in the highly active antiretroviral therapy era.

Engels EA, Pfeiffer RM, Landgren O, Moore RD.

J Acquir Immune Defic Syndr. 2010 May 1;54(1):78-84. doi: 10.1097/01.qai.0000371677.48743.8d.

17.

Circulating serum free light chains as predictive markers of AIDS-related lymphoma.

Landgren O, Goedert JJ, Rabkin CS, Wilson WH, Dunleavy K, Kyle RA, Katzmann JA, Rajkumar SV, Engels EA.

J Clin Oncol. 2010 Feb 10;28(5):773-9. doi: 10.1200/JCO.2009.25.1322. Epub 2010 Jan 4.

18.

A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma.

Bonnet F, Jouvencel AC, Parrens M, Leon MJ, Cotto E, Garrigue I, Morlat P, Beylot J, Fleury H, Lafon ME.

J Clin Virol. 2006 Aug;36(4):258-63. Epub 2006 Jun 9.

PMID:
16762591
19.

Dysregulated B-cell TLR2 expression and elevated regulatory B-cell frequency precede the diagnosis of AIDS-related non-Hodgkin lymphoma.

Siewe B, Pham JT, Cohen M, Hessol NA, Levine A, Martinez-Maza O, Landay A.

AIDS. 2015 Aug 24;29(13):1659-64. doi: 10.1097/QAD.0000000000000687.

20.

Serum soluble CD23 level correlates with subsequent development of AIDS-related non-Hodgkin's lymphoma.

Schroeder JR, Saah AJ, Hoover DR, Margolick JB, Ambinder RF, Martinez-Maza O, Breen EC, Jacobson LP, Variakojis D, Rowe DT, Armenian HK.

Cancer Epidemiol Biomarkers Prev. 1999 Nov;8(11):979-84.

Supplemental Content

Support Center